• 1
    Loury M, Kennedy DW. Chronic sinusitis and nasal polyposis. In: GetchellTV, DotyRL, BartoshukLM, SnowJBJr, editors. Smell and taste in health and disease. New York: Raven, 1991:517528.
  • 2
    European Academy of Allergology Clinical Immunology. European position paper on rhinosinusitis and nasal polyps. Rhinology 2005;18(Suppl. ):187.
  • 3
    Meltzer EO, Hamilos DL, Hadley JA, Lanza DC, Marple BF, Nicklas RA et al. Rhinosinusitis: establishing definitions for clinical research and patient care. J Allergy Clin Immunol 2004;114:155212.
  • 4
    Liu Z, Kim J, Sypek JP, Wang IM, Horton H, Oppenheim FG et al. Gene expression profiles in human nasal polyp tissues studied by means of DNA microarray. J Allergy Clin Immunol 2004;114:783790.
  • 5
    Singh G, Katyal SL. Clara cell proteins. Ann N Y Acad Sci 2000;923:4358.
  • 6
    Barnes PJ, Chung KF, Page CP. Inflammatory mediators of asthma: an update. Pharmacol Rev 1998;50:515596.
  • 7
    Murakami M, Kudo I. Phospholipase A2. J Biochem (Tokyo) 2002;131:285292.
  • 8
    Triggiani M, Granata F, Balestrieri B, Petraroli A, Scalia G, Del Vecchio L et al. Secretory phospholipases A2 activate selective functions in human eosinophils. J Immunol 2003;170:32793288.
  • 9
    Offer S, Yedgar S, Schwob O, Krimsky M, Bibi H, Eliraz A et al. Negative feedback between secretory and cytosolic phospholipase A2 and their opposing roles in ovalbumin-induced bronchoconstriction in rats. Am J Physiol Lung Cell Mol Physiol 2005;288:L523L529.
  • 10
    Lindbom J, Ljungman AG, Lindahl M, Tagesson C. Increased gene expression of novel cytosolic and secretory phospholipase A(2) types in human airway epithelial cells induced by tumor necrosis factor-alpha and IFN-gamma. J Interferon Cytokine Res 2002;22:947955.
  • 11
    Masuda S, Murakami M, Komiyama K, Ishihara M, Ishikawa Y, Ishii T et al. Various secretory phospholipase A2 enzymes are expressed in rheumatoid arthritis and augment prostaglandin production in cultured synovial cells. FEBS J 2005;272:655672.
  • 12
    Touqui L, Herpin-Richard N, Gene RM, Jullian E, Aljabi D, Hamberger C et al. Excretion of platelet activating factor-acetylhydrolase and phospholipase A2 into nasal fluids after allergenic challenge: possible role in the regulation of platelet activating factor release. J Allergy Clin Immunol 1994;94:109119.
  • 13
    Aho HJ, Grenman R, Sipila J, Peuravuori H, Hartikainen J, Nevalainen TJ. Group II phospholipase A2 in nasal fluid, mucosa and paranasal sinuses. Acta Otolaryngol 1997;117:860863.
  • 14
    Lindbom J, Ljungman AG, Lindahl M, Tagesson C. Expression of members of the phospholipase A2 family of enzymes in human nasal mucosa. Eur Respir J 2001;18:130138.
  • 15
    Lindbom J, Ljungman AG, Irander K, Lindahl M, Tagesson C. Phospholipase A2 mRNA expression in the nasal mucosa of healthy subjects and patients with seasonal allergic rhinitis. Rhinology 2004;42:8591.
  • 16
    Liu Z, Lu X, Wang H, Gao Q, Cui Y. The up-regulated expression of tenascin C in human nasal polyp tissues is related to eosinophil-derived transforming growth factor beta1. Am J Rhinol 2006;20:629633.
  • 17
    Jin Y, Suwa F, Nie X, George LT, Tamada Y, Fang YR et al. Bone morphogenetic protein-2,4,6 and transforming growth factor-β1 are induced in rat facial nuclei following motoneuron axotomy. Acta Histochem Cytochem 2003;36:231237.
  • 18
    Hauber HP, Daigneault P, Frenkiel S, Lavigne F, Hung HL, Levitt RC et al. Niflumic acid and MSI-2216 reduce TNF-alpha-induced mucin expression in human airway mucosa. J Allergy Clin Immunol 2005;115:266271.
  • 19
    Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 2001;25:402408.
  • 20
    Koduri RS, Gronroos JO, Laine VJ, Le Calvez C, Lambeau G, Nevalainen TJ et al. Bactericidal properties of human and murine groups I, II, V, X, and XII secreted phospholipases A(2). J Biol Chem 2002;277:58495857.
  • 21
    Masuda S, Murakami M, Ishikawa Y, Ishii T, Kudo I. Diverse cellular localizations of secretory phospholipase A2 enzymes in several human tissues. Biochim Biophys Acta 2005;1736:200210.
  • 22
    Masuda S, Murakami M, Mitsuishi M, Komiyama K, Ishikawa Y, Ishii T et al. Expression of secretory phospholipase A2 enzymes in lungs of humans with pneumonia and their potential prostaglandin-synthetic function in human lung-derived cells. Biochem J 2005;387:2738.
  • 23
    Bachert C, Wagenmann M, Rudack C, Hopken K, Hillebrandt M, Wang D et al. The role of cytokines in infectious sinusitis and nasal polyposis. Allergy 1998;53:213.
  • 24
    Bachert C, Gevaert P, Van Cauwenberge P. Staphylococcus aureus enterotoxins: a key in airway disease? Allergy 2002;57:480487.
  • 25
    Watelet JB, Bachert C, Claeys C, Van Cauwenberge P. Matrix metalloproteinases MMP-7, MMP-9 and their tissue inhibitor TIMP-1: expression in chronic sinusitis vs nasal polyposis. Allergy 2004;59:5460.
  • 26
    Watelet JB, Claeys C, Perez-Novo C, Gevaert P, Van Cauwenberge P, Bachert C. Transforming growth factor beta1 in nasal remodeling: differences between chronic rhinosinusitis and nasal polyposis. Am J Rhinol 2004;18:267272.
  • 27
    Pruzanski W, Stefanski E, Vadas P, Kennedy BP, Van Den Bosch H. Regulation of the cellular expression of secretory and cytosolic phospholipases A2, and cyclooxygenase-2 by peptide growth factors. Biochim Biophys Acta 1998;1403:4756.
  • 28
    Lennard CM, Mann EA, Sun LL, Chang AS, Bolger WE. Interleukin-1 beta, interleukin-5, interleukin-6, interleukin-8, and tumor necrosis factor-alpha in chronic sinusitis: response to systemic corticosteroids. Am J Rhinol 2000;14:367373.